2 dagar sedan · Earnings announcement* for HSTO: May 07, 2021. Data is currently not available. Histogen Inc. is estimated to report earnings on 05/07/2021. The upcoming earnings date is derived from an algorithm
Histogen (HSTO) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
March 11, 2021. Histogen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update. March 10, 2021. Stock analysis for Histogen Inc (HSTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- Inrikes fraktsedel mall
- Jobb ungdom malmo
- Tp inmatare
- Resultat rapport
- Valutakurser till deklarationen 2021
- Hk manager jobs in dubai
- Utbildningschef göteborg
- Scada medicin
- Appropriering wiki
- Anders lennartsson stockholm
Histogen last posted its earnings data on March 11th, 2021. The reported ($0.26) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.35) by $0.09. Histogen has generated $0.00 earnings per share over the last year. Histogen Inc., formerly Conatus Pharmaceuticals Inc., is a regenerative medicine company. The Company is focused on developing technologies that replace and regenerates tissues in the body.
0.75. Today ||| 52-Week Range.
Based on analysts offering 12 month price targets for HSTO in the last 3 months. The average price target is $5 with a high estimate of $5 and a low estimate of
0.75. Today ||| 52-Week Range.
Histogen is a regenerative medicine company with multiple product candidates in clinical development intended to address what Histogen believes to be underserved, multibillion dollar global markets. The Company’s patented technology focuses on replacing and regenerating tissues in the body with materials that have been shown to support human cell growth and differentiation.
forebay forebear forebitt forebode forebody foreboot forebush forecar forecast hispinae hisser hissing histie histioid histogen histoid histon histonal histone stockish stockman stockpot stocks stodge stodger stodgery stodgily stoechas Pluriseriated Design-on-stock.
It offers human multipotent cell conditioned media (CCM); human extracellular matrix (hECM); and hair stimulating complex (HSC). The company's technology focuses on stimulating a patient's own stem cells by delivering a complex of multipotent human
Histogen is a regenerative medicine company with multiple product candidates in clinical development intended to address what Histogen believes to be underserved, multibillion dollar global markets. The Company’s patented technology focuses on replacing and regenerating tissues in the body with materials that have been shown to support human cell growth and differentiation. Histogenics Stock Forecast, HSGX stock price prediction. Price target in 14 days: 0.238 USD. The best long-term & short-term Histogenics share price prognosis for
Histogen (HSTO) stock price, charts, trades & the US's most popular discussion forums.
Kriminalvården brinkeberg
On average, they expect Histogen's stock price to reach $5.00 in the next year.
Histogen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update. March 10, 2021. Stock analysis for Histogen Inc (HSTO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Hur hög bör avkastning på totalt kapital vara
hb management
tina se
inkomst försäkringskassan unionen
esselte svanströms
unionen semesterdagar i pengar
vagel översättning engelska
2021-04-01 · HSTO | Complete Histogen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
What this means for Palantir investors?